SS
Sprout Social, Inc. (SPT)·Q1 2025 Earnings Summary
Executive Summary
- Q1 2025 delivered a clean beat on both revenue and EPS, with revenue at $109.3M (+13% YoY) versus consensus ~$107.6M and non-GAAP EPS $0.22 versus ~$0.15; non-GAAP operating margin reached a record 11.5%, driven by stronger top-line execution and back-end-loaded hiring that lowered OpEx in the quarter .
- Remaining performance obligations (RPO) rose to $360.2M (+24% YoY), cRPO to $255.8M (+21% YoY), underscoring demand durability; management cited continued enterprise pipeline strength despite elongated procurement processes .
- Guidance was raised for FY 2025 (revenue to $448.9–$453.9M; non-GAAP operating income to $40.7–$45.7M; non-GAAP EPS to $0.69–$0.77), and new Q2 2025 guidance points to continued margin discipline; management remains measured on macro (tariffs, federal spending cuts) .
- Key catalysts: enterprise wins and multiproduct attach (Care, Influencer Marketing, AI Assist), deepening Salesforce Agentforce integration (GA), and product-led differentiation in AI, customer care, and influencer workflows .
What Went Well and What Went Wrong
What Went Well
- Record quarterly non-GAAP operating margin (11.5%) and non-GAAP free cash flow ($19.5M), reflecting disciplined growth and leverage; “we remain committed to growing operating leverage on a fiscal year basis” .
- Enterprise momentum: +22% YoY customers >$50k ARR, strategic logos (Fortune 500 medical device, food & beverage) and a $600k expansion with a Fortune 500 restaurant chain; “we’re expanding our sales capacity this year… further momentum” .
- Product leadership advances: GA of Salesforce Agentforce integration, AI Assist enhancements (generate posts, analyze charts), reimagined Influencer Marketing with AI natural language search; “we’ve made strategic updates… empower [customers] to lead the next era of marketing” .
What Went Wrong
- Sales cycles remain elongated and procurement processes are protracted; macro environment unchanged versus 2024, warranting measured guidance and caution on demand improvement .
- Deferred revenue declined sequentially (Q4→Q1), reflecting burn-off after unusually large Q4 annual/multiyear deals; CFO highlighted this seasonality and contract mix dynamic .
- Legal overhang: ongoing consolidated securities class action and derivative actions; company cannot estimate potential liability and notes outcomes could be material if adverse .
Financial Results
Core P&L (YoY/Sequential, with estimates comparison separately)
Margins
Revenue Breakdown
KPIs and Balance Highlights
Actual vs Wall Street Consensus (Q1 2025)
Values retrieved from S&P Global.*
Guidance Changes
Management does not guide GAAP operating loss or GAAP EPS due to variability in non-GAAP reconciling items .
Earnings Call Themes & Trends
Management Commentary
- CEO framing: “With the rapid shift toward social as a primary channel for discovery and engagement, we believe our investments in customer care, AI, and influencer marketing uniquely position us to lead brands through this transformation” .
- Enterprise focus: “We are expanding our sales capacity this year… drive further momentum in pipeline generation and enterprise coverage” .
- Product strategy: “Our reimagined influencer marketing product is grounded in AI… help brands find and vet the most valuable creators faster and safer than ever before” .
- Care proposition: “Enhanced Agentforce integration… accelerate case resolution with multichannel insights and personalized responses” .
- CFO on profitability: “Revenue overperformance and back-end-loaded hiring… benefited margins; if we continue to outperform top line, you’ll see more leverage” .
Q&A Highlights
- Enterprise pipeline health and ICP targeting: Management cited healthy enterprise pipeline creation, stronger hygiene and analytics from trials; customer care is mission-critical for large customers .
- Profitability drivers: Beat driven by revenue overperformance and back-end-loaded hiring; maintaining flexibility to invest while driving leverage with top-line outperformance .
- Deferred revenue dynamics: Sequential decline driven by burn-off from large annual/multiyear deals signed in Q4; seasonality flagged .
- Agentforce adoption: Integration just went GA; early stage, more showcases planned; expanding presence at Salesforce events .
- Macro/seasonality: Macro unchanged from 2024; business remains back-end weighted; guidance reflects a measured stance .
Estimates Context
- Q1 2025 beat vs consensus: Revenue $109.3M vs ~$107.6M*, non-GAAP EPS $0.22 vs ~$0.15*; signal of improving operating leverage and healthy enterprise mix .
- Q4 2024 context: Revenue $107.1M vs ~$106.7M*, non-GAAP EPS $0.19 vs ~$0.15*, foreshadowing sustained margin progress into Q1 .
- Near-term: Company’s Q2 revenue guide ($110.4–$111.2M) brackets consensus ~$110.94M*, suggesting in-line top-line with continued margin discipline .
Values retrieved from S&P Global.*
Key Takeaways for Investors
- Multiproduct platform strategy is gaining traction (Care, Influencer, AI Assist), improving ACV and enterprise mix—supportive of sustained margin expansion and higher cRPO growth .
- FY 2025 raise on revenue, operating income, and EPS indicates confidence in pipeline conversion and operating leverage, despite unchanged macro assumptions .
- Watch RPO/cRPO and deferred revenue seasonality: sequential deferred revenue declines from Q4 to Q1 are expected given contract timing; cRPO is converging with revenue over time as annual/multiyear mix grows .
- Salesforce partnership is a potential accelerant; GA Agentforce + Service Cloud integration elevates care workflows and may open new enterprise doors internationally via resellers .
- Legal matters remain an overhang; outcomes uncertain and could be material—factor into risk assessment and valuation framework .
- Near-term trading: Solid beat-and-raise with record margins provides a positive setup; monitor macro commentary and Q2 execution, especially enterprise deal timing and attach of premium modules .
- Medium term: If multiproduct attach and enterprise wins continue, the model can support improving NDR and durable FCF generation; sustained AI differentiation and care/influencer leadership are key to the thesis .
Non-GAAP Notes
- Q1 2025 exclusions included $19.8M stock-based compensation, $1.213M amortization of acquired intangibles, and $2.731M restructuring charges; reconciliations provided in the release .
- Company does not guide GAAP operating loss/EPS due to variability in non-GAAP adjustments (stock comp, amortization, restructuring) .